Showing results (1031-1040 of 11,582) with videos related to
Sort By:
Pageof 1,159
International Journal of Oncology|January 26, 1999
Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alphaV H Rao, R K Singh, D C Delimont, et al.International Journal of Oncology|January 26, 1999
Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washingK Junker, W Werner, C Mueller, et al.International Journal of Oncology|January 26, 1999
A high throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cellsT R Sharif, M SharifInternational Journal of Oncology|January 26, 1999
Irreversible cancer cell-induced functional anergy and apoptosis in resting and activated NK cellsM Cavalcanti, A Jewett, B BonavidaInternational Journal of Oncology|January 26, 1999
Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factorP J McLaughlin, I S Zagon, J SkitzkiInternational Journal of Oncology|January 5, 2006
Protein expression of the chemokine, CCL28, in human colorectal cancerJan Dimberg, Anders Hugander, Dick WågsäterInternational Journal of Oncology|January 5, 2006
Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumoursClelia Miracco, Maria Caterina De Nisi, Felice Arcuri, et al.International Journal of Oncology|January 5, 2006
Clinical significance of class III beta-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancerNaomi Urano, Yoshiyuki Fujiwara, Yuichiro Doki, et al.International Journal of Oncology|January 5, 2006
Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markersYukinori Kurokawa, Kimi Honma, Ichiro Takemasa, et al.International Journal of Oncology|January 5, 2006
Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivoY Zeng, X X Wu, M Fiscella, et al.Pageof 1,159